In this section
The Royal Children's Hospital Department of Endocrinology and Diabetes is one of the largest departments of its type in Australia. We have a national and international reputation as a leader in clinical care, research and training in paediatric endocrinology.
Our mission is to provide world-class service, research and training in the investigation and management of disorders of the endocrine system in children and adolescents. This primarily includes disorders related to hormonal dysfunction, but also includes a range of other conditions leading to abnormal growth or physical development.
Our department looks after young people from birth to late adolescence with a wide variety of hormone disorders, such as:
We also look after children with hormonal consequences of other conditions and their therapies such as:
For more information regarding the
weight management service and Prader Willi syndrome clinic, please refer to the
Department of Neurodevelopment and Disability.
We provide outreach services for young people with diabetes and other hormone disorders to many sites in regional Victoria, New South Wales and Tasmania.
We are committed to research to improve the health outcomes of both current and future generations. Our research activities focus on the key areas listed above, as part of the activities of the Murdoch Childrens Research Institute
Centre for Hormone Research. We have a particular emphasis on 'bench to clinic' or translational research. Our department is well represented in international and local journals, with publications across our
areas of interest.
Our team is also involved in teaching of both medical students and paediatric trainees, in order to provide them with appropriate grounding in important paediatric endocrine disorders. In addition, a large number of trainees, both local and international, have completed
fellowships in paediatric endocrinology in our unit. We are also involved in international teaching opportunities such as the European Society for Paediatric Endocrinology's Winter and African schools. Our education and training is linked to
The University of Melbourne Department of Paediatrics.
Please refer to the following documents regarding information regarding endocrine conditions and COVID-19, updated 31 March 2020:
Children with endocrine conditions
Children receiving growth hormone treatment
Children receiving glucocorticoid treatment
Australasian Paediatric Endocrine Group (APEG) COVID-19 resource page
Novo Nordisk has indicated that they not experiencing any supply constraints. Please refer to www.novonordisk.com.au for more information.
To ensure we minimise the spread of infection, we are in the process of reducing non-essential patient contact time and converting all possible upcoming consultations to Telehealth. Please refer to the following document for more information:
Telehealth guide for Endocrinology and Diabetes patients